Universal precautions to reduce stimulant misuse in treating adult ADHD.
In the United States, stimulants remain the approved pharmacotherapy of choice for adults with attention-deficit/hyperactivity disorder (ADHD). Many patients respond to these drugs, but stimulants also have a significant potential for misuse. This article suggests the "universal precautions" approach to reducing these risks while promoting appropriate medication use.
Connecticut Valley Hospital, Middletown, CT, USA. E-mail: vania.modesto-lowe@ct.gov.|Assistant Clinical Professor, Department of Psychiatry, University of Connecticut School of Medicine and Quinnipiac University, Farmington, CT, USA.
Vania
V
Modesto-Lowe
Community Mental Health Affiliates, New Britain, CT, USA.|Community Faculty, University of Connecticut and Quinnipiac University, Farmington, CT, USA.
Margaret
M
Chaplin
Mayo Clinic, Rochester, MN, USA.
Shirshendu
S
Sinha
Quinnipiac University, Hamden, CT, USA.
Katie
K
Woodard
D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D006801:Humans; D063487:Prescription Drug Misuse / Q000517:prevention & control*; D012307:Risk Factors
D000697:Central Nervous System Stimulants